Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
So you are really getting me mixed up with someone. Humor me please and let me know, where else did we have encounters and what is my name in other platforms?
Dude you are seriously one of the dumbest people I have encountered on any one of the boards. You and your analysis of who I am and my intentions. Plain old stupid. But, keep it up, it gives you some strange satisfaction
From the looks of it, nothings has changed, except for the Timing of certain goals.
Time to add 6-12 Months to all sell targets. Especially if they are selling 60M shares.
Well, that’s what I meant. Especially if there are folks who bought over .23 recently.
They may bring this down even more next week forcing more people to sell.
They may just wait a week or so prior to creating, “ Buy The Rumor” run for a couple weeks and then create another dip utilizing “Sell the News”
There has been a lot of numbers/predictions thrown around which suggested that it would have been and run after run after run and then more run, but we are all now seeing that, it is never a straightforward run, the way it was anticipated
Why so many people saying they received an email but no one has posted a SCREENSHOT?
A screenshot by any chance?
How about posting a screenshot if you received the email.
My belief is that, they are 100% Going To submit within Q2
The part I am not sure, if we will be informed within Q2 or right after (Monthly Update) possibly
Focus on the future, would, could, should has no place in stocks.
I was hoping that last 2 minute bam bam run.
Can they please close this over 30% today and tomorrow. Thanks
Good morning folks. Great time to be here. Happy Thursday.
Note:Mike & Rick, you are right, you are awesome, your knowledge is unbelievable, I wanna be more like you guys when I grow up, I wish there were more people like you on the planet.
Ok, now that the egos are massaged, let’s cut the bs and focus on how amazing life is.
Moving on
Sorry I just realized, it’s wasn’t a post, they replied to someone.
Vivos just posted on X saying “everything is on track for Q2” but them may have taken it down.
If you click on the link from one of previous messages here, it goes there
They literally just posted that for everyone on this board.
Talking directly to us without talking directly to us.
Good stuff
We aren’t there yet, tracking still showing “ on the way” deliver by “ end of Q2”
Amazon packages says “delivery on xxxxxxx, before the end of the day” and you don’t call Amazon around noon freaking out about your package and ask for a return on that day right? You wait till the end of the day
I think that many have created this illusion that it was “supposed to” have happened by now and created their own unnecessary disappointment. And the MMs, Smart Money spend millions of dollars to understand human psychology and how they behave, so they find ways to create demand (upward/downward)
Technically, there isn’t any Stall. But if you have told yourself “Monday” they yeah, there is stall.
It’s all good so far, nothing changed. Hang in there, learn how to be patient and master your emotions.
Something else to consider, when scare tactics are used, they aren’t trying to get you to sell right there and then, they may be trying to get you to lower your own future sell goals.
Let’s say you are committed to holding till x.xx and days like today may cause you to adjust that number to a much lower number as a result.
This all might be as simple as Technical factors. Charts, RSI…. Many Lagos, as well as individuals trade without even knowing what the company does, have no idea about fundamentals as well as their nearby plans.
Nothing changed folks.
Zoom out. Understandably it can be frustrating to see a decline, but big picture is still on our side
Hey man. Good to hear from you again. Btw, I really think that you have me mixed up with someone else or you have came to some strange conclusion about who I am and why I am here. It’s ok on my end, I just wouldn’t want you to waste more time on analyzing and responding to my posts from that perception of yours. Let’s mutually agree to never reply to each other anymore. Cheers
You and your buy out predictions are killing me a bit also makes me wanna say, what if. All and all, no Bo is happening for a while, ceo purchased shares recently
Its a Cup & Handle forming to see who can Handle the Handle and who can be patient and start drinking from the cup. Without a handle it would just be a Bowl and that would be very bowing
Sorry, I meant to reply directly to that comment about the tweet being "Unfortunate......"
Not sure how you concluded that. My thoughts were "We are about to release some big news and get on board with subscription, so you can hear directly from us"
This is an incredible opportunity to just relax & meditate or for some, medicate. Breath people breath
Welcome. Click on “Rooster” post history. He has posted a lot about these kind of stuff you are asking.
Ty
Hope it’s long term gains
If it’s going to increase 5% everyday until they submit, I hope they wait until final seconds of 2Q, I mean Why Not ey.
5% A Day will keep you day job away. Wink wink
Maybe it’s one of those 18% Fridays Again.
TGIF everyone
I have a feeling they are gonna turn up the heat after lunch. We may see 1M Candles and finish the day with over 10M
Now that the Demand is increasing, it’s an opportunity to Manipulate in their best interest. At the end of the day, they have 1 goal, do whatever it takes to transfer funds from Retail to “Smart Money” and they will use any strategy to achieve it. Mostly scarcity approach. They have imposters embedded here also.
Are you one of them? Speak the truth.
Kept asking more questions in regards to BDD and IDE in general and finallyasked ChatGPT to tie all of that info to Radiogel and this was the response
Radiogel, developed by Vivos Inc., recently received Breakthrough Device Designation (BDD) from the FDA for its Precision Radionuclide Therapy. This designation, granted in December 2023, acknowledges the potential of Radiogel to provide more effective treatment options for solid metastatic tumors, particularly in patients with papillary thyroid cancer who are not candidates for surgery or have declined it.
The BDD significantly benefits Radiogel's IDE submission process, which is currently in the final stages. This designation enhances the prioritization and support from the FDA, facilitating an accelerated review process. The FDA’s Breakthrough Devices program aims to expedite the development and review of innovative medical devices, providing timely access to therapies that can improve patient outcomes.
Radiogel's IDE submission will benefit from enhanced communication with the FDA, iterative feedback, and a streamlined review process. These factors collectively increase the likelihood of securing IDE approval for human clinical trials. Given the success rate and prioritization under the BDD program, Radiogel stands a strong chance of progressing efficiently through the IDE submission phase and advancing to clinical trials
I asked my friend Chat and this is what the reply was.
### After IDE Submission with BDD
1. **Interactive Review Process:**
- With BDD, the review process becomes more interactive. The FDA provides real-time feedback and may request additional information as needed. This iterative dialogue helps address potential issues quickly and efficiently.
2. **30-Day Review Period:**
- By regulation, the FDA must respond to an IDE application within 30 days. For a BDD device, this process is often expedited. The interactive nature of the review and the prioritization of BDD devices can lead to quicker resolutions of any issues identified during the review period.
- **Impact on 30-Day Period:** While the 30-day statutory review period remains in place, the engagement and iterative feedback allowed under BDD can effectively reduce the time taken to address any deficiencies, leading to a potentially faster approval to begin clinical trials. The FDA aims to expedite the development and review processes for BDD devices, which can result in a more efficient pathway through the IDE process.
3. **Conditional Approval:**
- If the FDA has minor concerns that can be addressed without delaying the start of the clinical trial, they may issue a conditional approval. This allows the trial to commence while the company addresses specific conditions outlined by the FDA.
4. **Full Approval:**
- Once all concerns are addressed and the FDA is satisfied with the application, full approval is granted. This permits the clinical trial to proceed according to the proposed protocol.
### Key Impacts of BDD on IDE Process
- **Enhanced Communication:** The ability to have more frequent and interactive communications with the FDA can help in identifying and resolving issues more quickly.
- **Prioritization:** BDD devices are given priority in the review process, which can shorten the overall timeline from submission to approval.
- **Reduced Review Time:** The iterative feedback and priority review can effectively reduce the time spent in the 30-day review period, allowing for a quicker transition to clinical trials.
- **Streamlined Approval:** The FDA's commitment to expedite the development and review processes for BDD devices can lead to a smoother and more predictable pathway through the IDE process.
Overall, the BDD can significantly enhance the efficiency of the IDE process, allowing for a more rapid progression from submission to clinical trials, ultimately benefiting patients with timely access to innovative medical technologies.
You are talking about these people
im·pos·tor
noun
noun: imposter
a person who pretends to be someone else in order to deceive others, especially for fraudulent gain.
👏👏👏👏✔️
To uplift from the Over-the-Counter (OTC) market to the Nasdaq Stock Market, a company must meet several minimum requirements, which generally include:
1. **Stockholders’ Equity**:
- **Nasdaq Capital Market**: At least $5 million.
- **Nasdaq Global Market**: At least $15 million.
- **Nasdaq Global Select Market**: At least $30 million.
2. **Market Value**:
- **Publicly Held Shares**: At least 1 million shares publicly held.
- **Market Value of Publicly Held Shares**: At least $15 million for the Capital Market, $8 million for the Global Market, and $110 million for the Global Select Market.
- **Market Value of Listed Securities**: Varies based on the market tier, often starting at around $50 million.
3. **Share Price**:
- **Minimum Bid Price**: At least $4 per share.
4. **Corporate Governance**:
- Compliance with Nasdaq's corporate governance standards, including having a majority of independent directors, an audit committee, and a code of conduct.
5. **Financial Criteria**:
- Depending on the market tier, financial criteria can include earnings, cash flow, or revenue thresholds. For example:
- **Capital Market**: Net income from continuing operations of at least $750,000 in the latest fiscal year or in two of the last three fiscal years.
- **Global Market**: Pre-tax earnings of at least $11 million in the latest three fiscal years, with at least $2.2 million in each of the two most recent years and positive amounts in all three years.
6. **Liquidity and Operating History**:
- Typically, companies must have at least 300 round lot shareholders and a minimum operating history of one year.
7. **Other Criteria**:
- Companies must be current in their SEC filings and have a minimum of three market makers.
These requirements ensure that companies listed on Nasdaq have sufficient financial strength, market interest, and governance structures to justify the move from the OTC market.
I asked ChatGPT
In the context of OTC (Over-the-Counter) markets, where stocks often have lower liquidity and higher volatility, red candles (indicating a decrease in stock price) right before a company is about to submit a crucial application could be attributed to several reasons, potentially involving stock manipulation. Here are some possible explanations:
1. Profit-Taking by Insiders
Insiders or those with privileged information might decide to sell off their shares to lock in profits before the anticipated event, causing a drop in stock price.
2. Market Maker Manipulation
Market makers might engage in strategic selling to drive the price down, aiming to create a buying opportunity at a lower price. This tactic, often referred to as "painting the tape," can be used to manipulate the perception of a stock's value.
3. Short Selling
Traders might engage in short selling, betting that the stock price will drop further. The anticipation of the application's submission might lead to uncertainty, prompting traders to sell short and drive the price down.
4. Rumors and Misinformation
The spread of negative rumors or misinformation about the company's application or its potential outcome can lead to panic selling. Competitors or other interested parties might deliberately disseminate false information to create uncertainty and drive the price down.
5. Stop-Loss Triggers
The presence of stop-loss orders set by retail investors or smaller institutional investors might be triggered by an initial drop in the stock price. This can create a cascade effect, where the triggered stop-loss orders cause further selling pressure.
6. Market Sentiment and Fear
General market sentiment or fear of a negative outcome from the application might lead investors to sell off their holdings. This could be driven by past experiences with similar applications or broader market conditions.
7. Low Liquidity Impact
In the OTC market, stocks often have lower liquidity. This means that even small sell orders can have a significant impact on the stock price, leading to red candles.
8. Pre-Positioning for a Post-Submission Rally
Some investors might sell shares to create a lower entry point, planning to buy back in after the application submission, anticipating a rally if the application is successful. This pre-positioning can create temporary downward pressure on the stock.
9. Regulatory Concerns
Concerns about regulatory scrutiny or potential issues with the application process itself might lead investors to exit their positions, fearing a negative outcome or delay.
10. Market Manipulation by Competitors
Competitors might engage in manipulative tactics to weaken the stock price of a rival company. This could be done to create a negative perception or to gain a competitive advantage.
Each of these factors can contribute to red candles in the stock price leading up to a critical event. Understanding the underlying reasons requires a detailed analysis of the specific stock, market conditions, and any available information regarding the company's upcoming application.